Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. The platform can assist in linking a team of domestic and foreign experts to provide accurate diagnosis and treatment programs. Treatment and management of IV-type tetrahydrocannabinol poisoning requires individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, and multidimensional management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved. Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to changes in the course of treatment. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of IV-type tetrahydrocannabinol poisoning.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.